Show simple item record

dc.contributor.authorBørøsund, Elin
dc.contributor.authorEhlers, Shawna
dc.contributor.authorVarsi, Cecilie
dc.contributor.authorClark, Matthew M.
dc.contributor.authorAndrykowski, Michael A.
dc.contributor.authorCvancarova, Milada
dc.contributor.authorNes, Lise Solberg
dc.coverage.spatialNorwayen_US
dc.date.accessioned2021-06-11T13:05:32Z
dc.date.available2021-06-11T13:05:32Z
dc.date.created2020-05-26T13:39:52Z
dc.date.issued2020-04-03
dc.identifier.citationCancer Medicine. 2020, 9 (11), 3775-3785).en_US
dc.identifier.issn2045-7634
dc.identifier.urihttps://hdl.handle.net/11250/2759013
dc.description.abstractBackground: In-person cognitive-behavioral stress-management interventions are consistently associated with reduced cancer distress. However, face-to-face delivery is an access barrier for many patients, and there is a need to develop remote-delivered interventions. The current study evaluated the preliminary efficacy of an application (app)-based cancer stress-management intervention, StressProffen, in a randomized controlled trial. Methods: Cancer survivors, maximum 1-year posttreatment (N = 172), were randomized to StressProffen (n = 84) or a usual care control group (n = 88). Participants received a blended delivery care model: (a) one face-to-face introduction session, (b) 10 app-based cognitive-behavioral stress-management modules, and (c) follow-up phone calls at weeks 2-3 and 6-7. Outcome measures included stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety Depression Scale), and health-related quality of life (HRQoL; Short-Form Health Surveys [SF-36]) at 3-months post-intervention, analyzed with change scores as dependent variables in linear regression models. Results: Participants were primarily women (82%), aged 20-78 years (mean 52, SD 11.2), with mixed cancer types (majority breast cancer; 48%). Analysis of 149 participants completing questionnaires at baseline and 3 months revealed significant intervention effects: decreased stress (mean difference [MD] −2.8; 95% confidence interval [CI], [−5.2 to −0.4]; P = .022) and improved HRQoL (Role Physical MD = 17.7, [CI 3.7-31.3], P = .013; Social Functioning MD = 8.5, [CI 0.7-16.2], P = .034; Role Emotional MD = 19.5, [CI 3.7-35.2], P = .016; Mental Health MD = 6.7, [CI 1.7-11.6], P = .009). No significant changes were observed for anxiety or depression. Conclusions: Digital-based cancer stress-management interventions, such as StressProffen, have the potential to provide easily accessible, effective psychosocial support for cancer survivors.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.ispartofseriesCancer Medicine;volume 9. issue 11
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectCanceren_US
dc.subjectCancer survivorsen_US
dc.subjectDistressen_US
dc.subjectHealth-care deliveryen_US
dc.subjectPsycho-oncologyen_US
dc.subjectStress-managementen_US
dc.titleResults from a randomized controlled trial testing StressProffen; an application‐based stress‐management intervention for cancer survivorsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 The Authors.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1002/cam4.3000
dc.identifier.cristin1812665
dc.source.journalCancer Medicineen_US
dc.source.volume9en_US
dc.source.issue11en_US
dc.source.pagenumber10en_US
dc.relation.projectKreftforeningen: 4602492-2013en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal